D.E. Shaw & Co’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,949
Closed -$1.65M 4057
2020
Q4
$1.65M Hold
2,949
﹤0.01% 2673
2020
Q3
$2.06M Buy
2,949
+772
+35% +$602K ﹤0.01% 2384
2020
Q2
$1.72M Hold
2,177
﹤0.01% 2528
2020
Q1
$1.3M Sell
2,177
-12,422
-85% -$12.1M ﹤0.01% 2531
2019
Q4
$16.6M Buy
14,599
+1,884
+15% +$2.05M 0.02% 911
2019
Q3
$15.1M Sell
12,715
-224
-2% -$342K 0.02% 914
2019
Q2
$21.3M Buy
12,939
+224
+2% +$388K 0.03% 716
2019
Q1
$25.9M Sell
12,715
-2,447
-16% -$4.31M 0.03% 616
2018
Q4
$19.5M Buy
15,162
+2,030
+15% +$3.11M 0.03% 726
2018
Q3
$24.8M Buy
13,132
+3,088
+31% +$6.38M 0.03% 673
2018
Q2
$20.4M Buy
10,044
+2,880
+40% +$6.56M 0.03% 715
2018
Q1
$15.8M Buy
7,164
+3,049
+74% +$7.76M 0.02% 768
2017
Q4
$9.49M Buy
4,115
+1,158
+39% +$2.35M 0.01% 1054
2017
Q3
$5.26M Buy
2,957
+1,413
+92% +$1.97M 0.01% 1340
2017
Q2
$2.1M Buy
+1,544
New +$1.86M ﹤0.01% 1946
2017
Q1
Sell
-3,860
Closed -$3.08M 3298
2016
Q4
$3.08M Hold
3,860
0.01% 1686
2016
Q3
$3.39M Hold
3,860
0.01% 1547
2016
Q2
$2.17M Hold
3,860
﹤0.01% 1883
2016
Q1
$2.13M Hold
3,860
﹤0.01% 1843
2015
Q4
$3.21M Buy
3,860
+1,544
+67% +$1.54M ﹤0.01% 1767
2015
Q3
$2.57M Buy
2,316
+525
+29% +$957K ﹤0.01% 1910
2015
Q2
$3.91M Buy
+1,791
New +$3.65M 0.01% 1658

Other funds holding BLUE

D.E. Shaw & Co's BLUE Position: Q3 2024 in Review

D.E. Shaw & Co sold out of bluebird bio (BLUE) in Q3 2024, closing a stake of 5,859 shares — an estimated $115K sold.

D.E. Shaw & Co first reported a position in BLUE in Q4 2014 and held it in 29 quarters. The position peaked at $20M in Q4 2017. 140 funds tracked by Wall St. Rank hold BLUE as of Q3 2024.

  • D.E. Shaw & Co reported no remaining bluebird bio position as of Q3 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 5,859 bluebird bio shares in Q3 2024, an estimated $115K.
  • D.E. Shaw & Co first reported a position in bluebird bio in Q4 2014 and held it in 29 quarters.
  • D.E. Shaw & Co's bluebird bio position peaked at $20M in Q4 2017.
  • 140 funds tracked by Wall St. Rank held bluebird bio as of Q3 2024.

Based on D.E. Shaw & Co's 13F filing for Q3 2024, filed 14 Nov 2024.